US 10172840
Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof
granted A61KA61K31/428A61K31/437
Quick answer
US patent 10172840 (Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof) held by VTV THERAPEUTICS LLC expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VTV THERAPEUTICS LLC
- Grant date
- Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/428, A61K31/437, A61K31/56, A61P